Fear-mongering about fentanyl for kids One expert characterized the DEA's claims as propaganda that was "divorced from reality" Salon · Sep 6, 2022
Cathie Wood's Psychedelics Fund ARK Analyzes The Sector's Present & Future And Likes What It Sees Cathie Wood’s ARK Genomic Revolution EFT has been making big investments in the psychedelics sector since February 2022, most notably in A Benzinga · Sep 6, 2022
Talented cricketer was supplying 'laughing gas' to Nottingham students Canisters of the drug were found in a car Nottingham Post · Sep 6, 2022
Argentina hikes biofuel prices for domestic market Argentina's government on Tuesday increased domestic prices of biodiesel for blending with diesel, as well as for bioethanol made from sugarcane and corn. Reuters · Sep 6, 2022
Tetra Partners With Cellvera To Develop An Oral Treatment For COVID-19 Tetra Bio-Pharma Inc. Benzinga · Sep 6, 2022
When will Omicron boosters be available? Who is eligible for Covid jab and how to book The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved a second Coronavirus booster vaccine to target the Omicron variant ahead of the autumn booster programme Daily Mirror · Sep 6, 2022
What is rotavirus and why is it in the news? Everything you need to know about rotavirus Evening Standard · Sep 5, 2022
The abortion rights movement can learn from the Aids activism of the 80s and 90s Act Up employed a multiplicity of tactics and responses while maintaining a laser-focused singleness of purpose The Guardian - US · Sep 5, 2022
CanSino's inhaled Covid-19 vaccine gets emergency use approval in China HONG KONG: China's CanSino Biologics Inc said on Sunday that its recently developed Covid-19 vaccine has been approved by the country's drug regulator for emergency use as a booster, potentially benefiting its business. Bangkok Post · Sep 4, 2022
CanSino's inhaled COVID-19 vaccine gets emergency use approval in China China's CanSino Biologics Inc said on Sunday that its recently developed COVID-19 vaccine has been approved by the country's drug regulator for emergency use as a booster, potentially benefiting its business. Reuters · Sep 4, 2022
Second Covid booster jab approved in UK ahead of winter vaccine programme It’s the second jab aimed at both the original and Omicron strains of the virus, to be approved in the UK Evening Standard · Sep 3, 2022
New 'second generation' Pfizer Covid vaccine approved ahead of booster programme The "bivalent" jab - which targets Omicron as well as the original strain of the deadly virus - is manufactured by Pfizer/Biotech, and follows a similar booster from Moderna approved last month Daily Mirror · Sep 3, 2022
A new vaccine which protects against two strains of covid has been approved for the NHS to use this autumn It targets both the original strain of coronavirus and the Omicron variant Manchester Evening News · Sep 3, 2022
Pfizer/BioNTech Covid-19 booster approved by UK medicines regulator The vaccine targets both the original strain of coronavirus and the Omicron variant. The Independent UK · Sep 3, 2022
The Guardian - AU · Sep 2, 2022 US-level mortality? Sounding the alarm about fentanyl overdose in Australia Deaths from the powerful opioid, along with pethidine and tramadol, are up a staggering 1,275% since 2006. A new report warns without ‘decisive action’ a crisis looms
The Independent UK · Sep 2, 2022 Pfizer criticised by conservatives for excluding white and Asian applicants from scholarship programme Company says scheme will boost minority representation
The Independent UK · Sep 2, 2022 FDA still skeptical of ALS drug ahead of high-stakes meeting The U.S. Food and Drug Administration has posted another negative review of a closely watched drug for the deadly neurodegenerative disease ALS
Al Jazeera · Sep 2, 2022 ‘Completely new’ COVID strains possible in winter: EU drug agency Existing vaccines and adaptive ones should protect people from serious illness and death, the EU agency says.
Benzinga · Sep 2, 2022 Is Cannabis Legalization The End For Pharma Stocks? New Study Predicts Billions In Losses Federal cannabis legalization might reduce conventional pharmaceutical sales by billions of dollars according to a new study cond
Radio France Internationale · Sep 2, 2022 EU regulator gives green light to omicron booster vaccines The European Medicines Agency (EMA) has backed two separate Covid-19 booster vaccines updated to target the omicron variant of Covid-19 and developed by drugmakers Moderna and BioNTech-Pfizer.
The Denver Post · Sep 2, 2022 New omicron COVID-19 boosters are coming. Here’s what you need to know DENVER — COVID-19 booster shots with a new omicron-targeting recipe are expected to arrive in pharmacies and clinics next week, but the experience of getting them will be largely the same as previous rounds of the vaccine.
Axios · Sep 2, 2022 "Game-changer" Paxlovid turns into pandemic enigma Paxlovid goes from COVID game-changer to pandemic enigma
Evening Standard · Sep 2, 2022 Alliance Pharma boss faces disqualification after CMA probe The healthcare firm denies conspiring to restrict the supply of anti-sickness drugs to the NHS
Axios · Sep 1, 2022 CDC recommends updated COVID-19 boosters The CDC recommends the new Pfizer-BioNTech booster for individuals 12 years and the Moderna vaccine for individuals 18 and up.
Bangkok Post · Sep 1, 2022 Innobic in talks with potential partner Innobic (Asia) Co, the life science arm of national oil and gas conglomerate PTT Plc, is seeking a new business partner in Iceland in a fresh move to produce medicines to treat cancer.